Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.62 - $0.85 $2,356 - $3,230
-3,800 Reduced 7.63%
45,996 $38,000
Q2 2023

Aug 14, 2023

BUY
$1.04 - $1.4 $51,787 - $69,714
49,796 New
49,796 $55,000
Q2 2022

Aug 15, 2022

SELL
$0.67 - $1.4 $23,927 - $49,998
-35,713 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.89 - $4.43 $945 - $1,448
-327 Reduced 0.91%
35,713 $116,000
Q2 2021

Aug 16, 2021

BUY
$2.82 - $5.01 $16,034 - $28,486
5,686 Added 18.73%
36,040 $151,000
Q1 2021

May 17, 2021

SELL
$2.92 - $5.07 $2,639 - $4,583
-904 Reduced 2.89%
30,354 $137,000
Q4 2020

Feb 16, 2021

BUY
$1.64 - $3.42 $12,578 - $26,231
7,670 Added 32.52%
31,258 $95,000
Q2 2020

Aug 14, 2020

BUY
$1.83 - $4.06 $43,166 - $95,767
23,588 New
23,588 $67,000
Q2 2019

Aug 14, 2019

SELL
$1.79 - $3.05 $21,535 - $36,694
-12,031 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$1.47 - $3.06 $17,685 - $36,814
12,031 New
12,031 $29,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.